13
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Hepatocellular damage in porcine endotoxemia: beneficial effects of selective versus non-selective nitric oxide synthase inhibition?

Pages 503-512 | Published online: 08 Jul 2009

  • Parrillo JE. Pathogenetic mechanisms of septic shock [Review]. N Engl J Med 1993; 328: 1471-7.
  • Thiemermann C. Nitric oxide and septic shock [Review]. Gen Pharmacol 1997; 29: 159-66.
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology [Review]. Pharmacol Rev 1991; 43: 109-42.
  • Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C14 24-37.
  • Klabunde RE, Ritger RC. NG-monomethyl-Larginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991; 178: 1135*0.
  • Saetre T, Smiseth OA, Scholz T, Carlsen H, Nordsletten L, Fahlstrom E, Aasen AO. Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am J Physiol 1996; 271: H1325-32.
  • Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990; 48: 565-9.
  • Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, Simmons RL. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992; 20: 1568-74.
  • Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.
  • Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995; 114: 510-6.
  • Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen AO. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 1998; 9: 109-15.
  • Vos TA, Gouw AS, Klok PA, Havinga R, van Goor H, Huitema S, Roelofsen, H, Kuipers F, Jansen PL, Moshage H. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113: 1323-33.
  • Fink MP. Adequacy of gut oxygenation in endotoxemia and sepsis [Review]. Crit Care Med 1993; 21: Suppl: S4-8.
  • Gundersen Y, Saetre T, Scholz T, Carlsen H, Kjekshus H, Smiseth OA, Lilleaasen P, Aasen AO. The NO donor sodium nitroprusside reverses the negative effects on hepatic arterial flow induced by endotoxin and the NO synthase inhibitor L-NAME. Eur Surg Res 1996; 28: 323-32.
  • Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91: 12472-6.
  • Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995; 116: 2845-51.
  • Gundersen Y, Saetre T, Scholz T, Hovig T, Lilleaasen P, Aasen AO. Selective inhibition of inducible nitric oxide synthase maintains haemodynamic stability without untoward consequences for hepatic function or morphology. Eur J Surg 1999; 165:1167-74.
  • Wray GM, Millar CG, Hinds CJ, Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 1998; 9: 329-35.
  • Rappaport AM. Hepatic blood flow: morphologic aspects and physiologic regulation [Review]. Intern Rev Physiol 1980; 21: 1-63.
  • Cornelius CE. Liver function. In: Anonymous. Clinical biochemistry of domestic animals. New York: Academic Press Inc., 1989: 364-92.
  • Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications [Review]. Adv Clin Chem 1993; 30: 281-380.
  • Redl H, Schlag G, Paul E, Davies J. Plasma glutathione S-transferase as an early marker of posttraumatic hepatic injury in non-human primates. Shock 1995; 3: 395-7.
  • Schon MR, Akkoc N, Schrem H, Keech G, Krautlein K, Lemmens HP, Wolf S, Tominaga M, Kollmar O, Neuhaus P. Alpha-glutathione-S-transferase is a sensitive marker of hepatocellular damage due to warm or cold ischemia in pig liver transplantation. Transplant Proc 1997; 29: 3036-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.